Speaker illustration

Doctor Matteo Parollo

Azienda Ospedaliero Universitaria Pisana, Pisa (Italy)

Member of:

European Heart Rythm Association

Cardiovascular Diseases Resident at University of Pisa.

Non-invasive continuous arterial pressure monitoring during transcatheter atrial fibrillation ablation: a feasibility prospective study

Event: EHRA 2022

Topic: Rhythm Control, Catheter Ablation

Session: Moderated ePosters - Update on new techonologies and strategies to improve outcome of atrial fibrillation ablation

Thumbnail

Feasibility and long-term outcomes of leadless pacemaker implant after transvenous lead extraction

Event: EHRA 2022

Topic: Antibradycardia Pacing

Session: ePosters Day 2

Thumbnail

Just a pinch of salt: usefulness of intrapericardial half-normal saline to avoid phrenic nerve damage in epicardial VT ablation.

Event: EHRA 2022

Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Session: Clinical case session

Thumbnail

Painful right ventricular pacing in absence of perforation treated successfully with His bundle pacing.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Antibradycardia Pacing

Session: Pacing

Thumbnail

The addition of strict stability criteria does not reduce recurrences after atrial fibrillation ablation using ablation index and can impact on procedure efficiency

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation ePosters

Thumbnail

Impact of ablation index on paroxysmal atrial fibrillation ablation: a comparison with an automated lesion tagging tool using average force and strict stability criteria

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation - Treatment

Thumbnail

Impact of intraprocedural electrical cardioversion and the use of contact force sensing catheters on atrial fibrillation recurrences after pulmonary vein isolation: a single centre experience

Event: EHRA 2018

Topic: Catheter Ablation of Arrhythmias

Session: Atrial fibrillation ablation - Mechanisms and outcomes

Thumbnail

This platform is supported by

logo Novo Nordisk